Bud Selig

Bud Selig issues his official statement on the Biogenesis suspensions

68 Comments

If there was ever a time for this pic, it’s now.

source: Reuters

Bud’s official statement:

“Major League Baseball has worked diligently with the Players Association for more than a decade to make our Joint Drug Program the best in all of professional sports.  I am proud of the comprehensive nature of our efforts – not only with regard to random testing, groundbreaking blood testing for human Growth Hormone and one of the most significant longitudinal profiling programs in the world, but also our investigative capabilities, which proved vital to the Biogenesis case.  Upon learning that players were linked to the use of performance-enhancing drugs, we vigorously pursued evidence that linked those individuals to violations of our Program.  We conducted a thorough, aggressive investigation guided by facts so that we could justly enforce our rules.

“Despite the challenges this situation has created during a great season on the field, we pursued this matter because it was not only the right thing to do, but the only thing to do.  For weeks, I have noted the many players throughout the game who have strongly voiced their support on this issue, and I thank them for it.  I appreciate the unwavering support of our owners and club personnel, who share my ardent desire to address this situation appropriately.  I am also grateful to the Professional Baseball Athletic Trainers Society and our club physicians, who were instrumental in the banning of amphetamines and whose expertise remains invaluable to me.  As an institution, we have made unprecedented strides together.

“It is important to point out that 16,000 total urine and blood tests were conducted on players worldwide under MLB Drug Programs in 2012.  With the important additions of the hGH testing and longitudinal profiling this season, we are more confident than ever in the effectiveness of the testing program.  Those players who have violated the Program have created scrutiny for the vast majority of our players, who play the game the right way.

“This case resoundingly illustrates that the strength of our Program is not limited only to testing.  We continue to attack this issue on every front – from science and research, to education and awareness, to fact-finding and investigative skills.  Major League Baseball is proud of the enormous progress we have made, and we look forward to working with the players to make the penalties for violations of the Drug Program even more stringent and a stronger deterrent.

“As a social institution with enormous social responsibilities, Baseball must do everything it can to maintain integrity, fairness and a level playing field.  We are committed to working together with players to reiterate that performance-enhancing drugs will not be tolerated in our game.”

Angels’ Pujols has foot surgery, could be sidelined 4 months

pujols
Getty Images
Leave a comment

ANAHEIM, Calif. — Los Angeles Angels slugger Albert Pujols had surgery on his right foot Friday, possibly sidelining him past opening day.

Angels general manager Billy Eppler said Pujols had the procedure Friday in North Carolina to release his plantar fascia, the ligament connecting the heel to the toes. The three-time NL MVP was bothered by plantar fasciitis repeatedly during the season, but played through the pain in arguably the strongest year of his half-decade with the Angels.

Eppler said the surgery typically prevents players from participating in baseball activities for three months, along with another month before they’re ready to resume playing in games. Opening day for Los Angeles is April 3, and the Angels hope Pujols can be ready.

“He’s at that point in his career where he’s keenly aware of what’s happening with his body,” Eppler said in a phone interview. “I don’t put the timetable on Albert like you would with your younger players. We’ll just see in Albert’s case, as he progresses, what his timetable is.”

Pujols, who turns 37 next month, batted .268 last year with 31 homers and 119 RBIs, the fourth-most in the majors – although his .780 OPS was among the worst of his career. He largely served as a designated hitter instead of playing first base due to problems with his hamstrings and feet.

Pujols heads into 2017 with 591 career homers, ranking him ninth in major league history. He is 18 homers behind Sammy Sosa for eighth place.

After playing in pain until the final week of the Angels’ disappointing season, Pujols began shock wave therapy on his foot early in the offseason, believing he wouldn’t need surgery.

But Pujols’ foot became more painful in recent weeks despite the therapy, and he huddled with the Angels’ top brass to decide on surgery after his most recent trip to see Dr. Robert Anderson in North Carolina. Continuing with conservative care would have required 10 more weeks, forcing Pujols to miss the first half of the 2017 season if he still required surgery.

“He just felt that the pain had gotten to a point where he was comfortable” having surgery, Eppler said. “If we did delay it, you’re just looking at 2 1/2 more months into the season.”

Pujols had a different type of surgery on his right foot last winter, but recovered in time for opening day. He also had plantar fasciitis in his left foot during the 2013 season, eventually forcing him out for the year when his fascia snapped.

Pujols has five years and $140 million remaining on the 10-year, $240 million free-agent contract that pried him out of St. Louis, where he won two World Series and became a nine-time NL All-Star.

The Angels haven’t won a playoff game since Pujols’ arrival and Mike Trout‘s concurrent emergence as one of baseball’s best players. They went 74-88 last season, the injury-plagued club’s worst record since 1999.

Diamondbacks hire Mike Fitzgerald to head Research and Development department

BOSTON, MA - SEPTEMBER 24:  Mike Hazen, new Senior Vice President and General Manager of the Red Sox, addresses the media during a press conference to announce his promotion before the game against the Tampa Bay Rays at Fenway Park on September 24, 2015 in Boston, Massachusetts.  (Photo by Maddie Meyer/Getty Images)
Getty Images
Leave a comment

According to an official announcement, the Diamondbacks have acquired former Pirates quantitative analyst Mike Fitzgerald as their new Director of Research and Development.

Fitzgerald joined the Pirates’ front office in 2012, where he frequently accompanied the team on the road to help breach the divide between analytics and the clubhouse. According to a profile written by Grantland’s Ben Lindbergh in 2014, Fitzgerald’s multifaceted approach brought balance and perspective to the organization, whether he was assisting coaches in making statistically sound decisions, optimizing the batting order, weighing in on scouting and personnel decisions, developing more effective defensive positioning, or keeping players and personnel appraised of the latest developments in sabermetrics.

In the wake of Fitzgerald’s departure, Pirates’ GM Neal Huntington praised the Diamondbacks for a smart acquisition and said that the club has every intention of finding a replacement analyst, albeit one who will have some big shoes to fill.